imiquimod has been researched along with maxacalcitol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, Y; Hau, CS; Kadono, T; Kamata, M; Mitsui, A; Sato, S; Shibata, S; Shimizu, T; Sugaya, M; Tada, Y; Takeoka, S; Watanabe, S | 1 |
| Enomoto, Y; Fukuda, H; Hirata, A; Nagasawa, T; Niiyama, S | 1 |
2 other study(ies) available for imiquimod and maxacalcitol
| Article | Year |
|---|---|
The vitamin D
Topics: Adoptive Transfer; Animals; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Down-Regulation; Female; Humans; Imiquimod; Interleukin-17; Interleukin-23; Mice; Mice, Inbred BALB C; Psoriasis; Skin; T-Lymphocytes, Regulatory; Treatment Outcome | 2018 |
Successful treatment of porocarcinoma with maxacalcitol and imiquimod.
Topics: Aged, 80 and over; Antineoplastic Agents; Calcitriol; Eccrine Porocarcinoma; Female; Humans; Imiquimod; Sweat Gland Neoplasms; Treatment Outcome | 2019 |